XJR - ETF AI Analysis
Top Page
iShares ESG Screened S&P Small-Cap ETF (XJR)
Rating:66Neutral
Price Target:―
Positive Factors
Strong Recent Performance
The ETF has delivered strong gains so far this year and over the past few months, showing solid recent momentum.
Broad Sector Diversification
Holdings are spread across many sectors, including financials, industrials, technology, health care, and consumer companies, which helps reduce the impact of weakness in any single area.
Low Expense Ratio
The fund’s relatively low annual fee means more of the investment’s returns stay in investors’ pockets over time.
Negative Factors
Heavy U.S. Concentration
With almost all assets in U.S. stocks, the ETF offers little geographic diversification and is highly tied to the U.S. economy.
Small-Cap Volatility Risk
Because it focuses on smaller companies, the fund may experience larger price swings and sharper drawdowns than funds holding bigger, more established firms.
Top Holdings in Specialized Sectors
Several leading positions are in niche health care and technology names, which can be more sensitive to company-specific news and regulatory changes.
XJR vs. SPDR S&P 500 ETF (SPY)
AUM214.16M
RegionNorth America
Expense Ratio0.12%
Beta0.94
IssueriShares
Inception DateSep 22, 2020
Dividend Yield0.93%
Asset ClassEquity
Index TrackedS&P SmallCap 600 Sustainability Screened Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume6,699
30 Day Avg. Volume8,694
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
60.99Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering532
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
XJR Summary
XJR is the iShares ESG Screened S&P Small-Cap ETF, which follows the S&P SmallCap 600 Sustainability Screened Index. It invests in smaller U.S. companies that meet certain environmental, social, and governance (ESG) standards. The fund spreads money across many sectors, including health care, technology, and financials, with holdings like Molina Healthcare and Match Group. Investors might consider XJR for growth potential from small companies plus diversification, while supporting businesses that follow ESG practices. A key risk is that small-cap stocks can be more volatile, so the value of the ETF can go up and down sharply with the market.
How much will it cost me?The iShares ESG Screened S&P Small-Cap ETF (XJR) has an expense ratio of 0.12%, which means you’ll pay $1.20 per year for every $1,000 invested. This is lower than average for ETFs because it is passively managed, tracking an index rather than relying on active management.
What would affect this ETF?The iShares ESG Screened S&P Small-Cap ETF (XJR) could benefit from growing interest in ESG investing and the innovative potential of small-cap companies, particularly in sectors like technology and industrials. However, it may face challenges from economic slowdowns, rising interest rates, or regulatory changes that impact small-cap firms disproportionately. Its focus on U.S. companies also makes it sensitive to domestic economic conditions and policy shifts.
XJR Top 10 Holdings
XJR leans into U.S. small-cap growth stories with an ESG twist, and a handful of names are doing the heavy lifting. Corcept Therapeutics and ViaSat have been rising steadily, giving the fund a strong tailwind from health care and tech. Glaukos and Alkermes add more health care punch, with momentum that’s mostly supportive despite some recent wobbling. On the other side, FormFactor and Element Solutions have been lagging in the near term, showing that the fund’s tech and industrial bets can cut both ways. Overall, it’s a diversified U.S. small-cap mix, but with a clear tilt toward innovative health care and technology players.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Corcept Therapeutics | 0.74% | $1.58M | $13.09B | 73.82% | 76 Outperform | |
| Glaukos | 0.69% | $1.48M | $10.91B | 96.38% | 61 Neutral | |
| ViaSat | 0.64% | $1.37M | $10.20B | 167.52% | 56 Neutral | |
| Brinker International | 0.64% | $1.37M | $9.74B | 63.60% | 70 Neutral | |
| Match Group | 0.60% | $1.28M | $9.26B | 9.57% | 66 Neutral | |
| Paycom | 0.60% | $1.28M | $10.04B | -2.06% | 76 Outperform | |
| Protagonist Therapeutics | 0.58% | $1.24M | $9.75B | 168.48% | 68 Neutral | |
| Formfactor | 0.57% | $1.23M | $9.04B | 291.50% | 68 Neutral | |
| Ryman | 0.56% | $1.20M | $8.12B | 29.92% | 66 Neutral | |
| CarMax | 0.55% | $1.18M | $8.66B | 3.45% | 61 Neutral |
XJR Technical Analysis
Positive
―
Price Trends
51.80
Positive
49.66
Positive
46.65
Positive
Market Momentum
0.18
Positive
48.48
Neutral
7.29
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For XJR, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 52.32, equal to the 50-day MA of 51.80, and equal to the 200-day MA of 46.65, indicating a neutral trend. The MACD of 0.18 indicates Positive momentum. The RSI at 48.48 is Neutral, neither overbought nor oversold. The STOCH value of 7.29 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for XJR.
XJR Peer Comparison
Comparison Results
Performance Comparison
XJR
iShares ESG Screened S&P Small-Cap ETF
51.96
9.99
23.80%
OUSM
OShares U.S. Small-Cap Quality Dividend ETF
―
―
―
SFLO
VictoryShares Small Cap Free Cash Flow ETF
―
―
―
SMDV
ProShares Russell 2000 Dividend Growers ETF
―
―
―
BBSC
JPMorgan BetaBuilders U.S. Small Cap Equity ETF
―
―
―
JHSC
John Hancock Multifactor Small Cap ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents